Literature DB >> 8055223

Diagnosis and treatment of intestinal helminths. I. Common intestinal cestodes.

H B Tanowitz1, L M Weiss, M Wittner.   

Abstract

Increase in travel and immigration has led to a heightened awareness of parasitic diseases among health professionals. Intestinal helminths are important human parasites. Cestodes or tapeworms comprise an important group of helminths. The diagnosis of tapeworm infections requires a skilled laboratory because serological tests are unavailable. In this first part of our review of intestinal helminths, we describe the salient features of the diagnosis and treatment of several important intestinal cestodes, including Diphyllobothrium latum, Taenia, Hymenolepis, and Dipylidium caninum. Niclosamide and praziquantel are the drugs of choice for tapeworm infections.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8055223

Source DB:  PubMed          Journal:  Gastroenterologist        ISSN： 1065-2477


  12 in total

1.  Hymenolepis diminuta Infection in a School Going Child: First Case Report from Uttarakhand.

Authors:  Pratima Gupta; Priyanka Gupta; Bhanu Kiran Bhakri; Neelam Kaistha; Balram Ji Omar
Journal:  J Clin Diagn Res       Date:  2016-09-01

2.  Development and validation of a quantitative, high-throughput, fluorescent-based bioassay to detect schistosoma viability.

Authors:  Emily Peak; Iain W Chalmers; Karl F Hoffmann
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

3.  Niclosamide suppresses macrophage-induced inflammation in endometriosis†.

Authors:  Nikola Sekulovski; Allison E Whorton; Tomoki Tanaka; Yasushi Hirota; Mingxin Shi; James A MacLean; Julio Ricardo Loret de Mola; Kathleen Groesch; Paula Diaz-Sylvester; Teresa Wilson; Kanako Hayashi
Journal:  Biol Reprod       Date:  2020-04-24       Impact factor: 4.285

4.  Niclosamide's potential direct targets in ovarian cancer†.

Authors:  Nikola Sekulovski; James A MacLean; Sambasiva R Bheemireddy; Zhifeng Yu; Hiroshi Okuda; Cindy Pru; Kyle N Plunkett; Martin Matzuk; Kanako Hayashi
Journal:  Biol Reprod       Date:  2021-08-03       Impact factor: 4.285

5.  Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.

Authors:  Wenyan Lu; Cuihong Lin; Michael J Roberts; William R Waud; Gary A Piazza; Yonghe Li
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

6.  Co-infections of malaria and geohelminthiasis in two rural communities of Nkassomo and Vian in the Mfou health district, Cameroon.

Authors:  Francis Zeukeng; Viviane Hélène Matong Tchinda; Jude Daiga Bigoga; Clovis Hugues Tiogang Seumen; Edward Shafe Ndzi; Géraldine Abonweh; Valérie Makoge; Amédée Motsebo; Roger Somo Moyou
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16

7.  Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.

Authors:  Britta Stadelmann; Reto Rufener; Denise Aeschbacher; Markus Spiliotis; Bruno Gottstein; Andrew Hemphill
Journal:  PLoS Negl Trop Dis       Date:  2016-03-11

8.  Niclosamide loaded biodegradable chitosan nanocargoes: an in vitro study for potential application in cancer therapy.

Authors:  Saba Naqvi; Shanid Mohiyuddin; P Gopinath
Journal:  R Soc Open Sci       Date:  2017-11-08       Impact factor: 2.963

9.  Niclosamide suppresses renal cell carcinoma by inhibiting Wnt/β-catenin and inducing mitochondrial dysfunctions.

Authors:  Juan Zhao; Qiushan He; Zhimin Gong; Sen Chen; Long Cui
Journal:  Springerplus       Date:  2016-08-30

10.  Niclosamide sensitizes nasopharyngeal carcinoma to radiation by downregulating Ku70/80 expression.

Authors:  Jingjing Li; Haiwen Li; Dechao Zhan; Mei Xiang; Jun Yang; Yufang Zuo; Yin Yu; Hechao Zhou; Danxian Jiang; Haiqing Luo; Zihong Chen; Zhonghua Yu; Zumin Xu
Journal:  J Cancer       Date:  2018-02-06       Impact factor: 4.207
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.